Call: +8801842077322 || Email: abdullahpharma.bd@gmail.com
Facebook Twitter WhatsApp WhatsApp Telegram
  • CONTACT US
  • FAQs
Facebook Twitter WhatsApp WhatsApp Telegram
Abdullah Pharma Abdullah Pharma
Select category
  • Select category
  • Anti-Diabetic
    • Bladder Cancer
    • Breast Cancer
    • Colon & Rectal Cancer
    • Colorectal Cancer
  • BEST SELLER
  • Diabetic
    • Endometrial Cancer
    • Hepatitis B Virus
    • Hepatitis C Virus
    • Ibrutinib
    • Kidney Cancer
    • Leukaemia
    • Liver Cancer
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
    • Renal Cell Carcinoma
    • Rheumatoid Arthritis
    • Thrombocytopenia
    • Thyroid Cancer
    • Tumors Cancer
Login / Register
0 Wishlist
0 Compare
0 items / £0.00
Menu
Abdullah Pharma Abdullah Pharma
0 items / £0.00
Browse Categories
  • Anti-Diabetic
  • Bladder Cancer
  • Breast Cancer
  • Colon & Rectal Cancer
  • Colorectal Cancer
  • Diabetic
  • Endometrial Cancer
  • Hepatitis B Virus
  • Hepatitis C Virus
  • Kidney Cancer
  • Ibrutinib
  • Liver Cancer
  • BEST SELLER
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
  • Renal Cell Carcinoma
  • Rheumatoid Arthritis
  • Thrombocytopenia
  • Thyroid Cancer
  • Tumors Cancer
  • Home
  • ONCOLOGY PRODUCTS
  • About Us
  • UPLOAD PRESCRIPTION
WEDICA 100 MG
Click to enlarge
HomeDiabeticLiver Cancer WEDICA 100 MG
Previous product
VOTRIENT 200 MG
VOTRIENT 200 MG
Back to products
Next product
XITABIN
XITABIN

WEDICA 100 MG

Compare
Add to wishlist
Categories: Anti-Diabetic, BEST SELLER, Diabetic, Endometrial Cancer, Liver Cancer, Lymphoma, ONCOLOGY PRODUCTS, Ovarian Cancer, Pancreatic Cancer, Peritoneal Cancer, Primary Biliary Cirrhosis, Renal Cell Carcinoma, Rheumatoid Arthritis, Thrombocytopenia Tags: ACLOPAIN, Afatinib Dimaleate INN, ALECNIB 150 MG, Anti-viral, Baricinix Tablet, Beacon Pharmaceuticals Ltd., Biotech Products, Cancer Medicine in Bangladesh, LARONIB, Oncology Medicine Supplier in Bangladesh, Oncology Medicines, Oncology Medicines in Bangladesh, WEDICA, WEDICA 100 MG
Share
Facebook Twitter WhatsApp WhatsApp Telegram
  • Description
  • Reviews (0)
  • Shipping & Delivery
Description

Tablet Wedica Tablet

Trelagliptin Succinate
100 mg
Beacon Pharmaceuticals Ltd.

Indications

Trelagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a highly selective dipeptidyl peptidase-4 inhibitor that is typically used as an add on treatment when the first line treatment of metformin is not achieving the expected glycemic goals; though it has been approved for use as a first line treatment when metformin cannot be used.

Therapeutic Class

Dipeptidyl Peptidase-4 (DPP-4) inhibitor

Pharmacology

It controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones that play an important role in blood glucose regulation. The inhibition of DPP-4 increases insulin secretion depending on blood glucose concentration, thereby controlling blood glucose levels. It is indicated for the treatment of type 2 diabetes.

Dosage & Administration

100 mg of Trelagliptin is administered to adults once weekly by mouth. This has lesser hypoglycemic events and 4 and 12-fold more potent than Alogliptin and Sitagliptin.

Contraindications

Study subjects meeting any of the following criteria will not be included in this study:

  • Patients under treatment with trelagliptin for type 2 diabetes at the start of screening.
  • Patients with a diagnosis of type 1 diabetes.
  • Patients with severe renal impairment or renal failure (e.g., eGFR < 30 mL/min/1.73 m2 or on dialysis).
  • Patients with serious heart disease or a cerebrovascular disorder, or a serious pancreatic, blood, or other disease.
  • Patients with a history of gastrointestinal resection.
  • Patients with a proliferative diabetic retinopathy.
  • Patients with malignancy.
  • Patients with a history of hypersensitivity or allergy to DPP-4 inhibitors.
  • Patients who are pregnant, breast-feeding, possibly pregnant, or planning to become pregnant.
  • Patients who may need to add or discontinue concomitant medication or change the dose during the study period.
  • Patients who will require treatment with a prohibited concomitant medication during the study period.
  • Patients participating in other clinical studies.
  • Patients assessed as ineligible for any other reason by the investigators.

Side Effects

Among 901 domestic clinical trial cases up to the time of approval, 103 cases ( 11.4%) showed clinical results that included abnormalities and side effects. These mainly included hypoglycemia, nasopharyngitis, and elevated lipase.

Given the appearance of serious side effects such as hypoglycemia (0.1~5%) , administer medication in conjunction with close observation of patient status. Other DPP-4 inhibitors have been reported to present serious hypoglycemia in combination with Sulfonylurea medications as well as some cases of loss of consciousness. Moreover, decreased blood sugar from the use of this medication, once confirmed, can be remedied by giving sucrose. However, hypoglycemia resulting from a combination with glucosidase inhibitors should be treated with fructose.

Pregnancy & Lactation

No study has performed in patients who are pregnant, breast-feeding, possibly pregnant, or planning to become pregnant.

Precautions & Warnings

(provide cautious dosage to the following patients): The following patients or circumstances

  • Patients with moderate kidney function disorder
  • Patients undergoing treatment with sulfonylurea drugs or insulin medication [there are reports of severe hypotension with use in combination with other DPP-4 inhibitors]
  • Hypopituitarism or hypoadrenalism
  • Malnutrition, starvation, irregular eating patterns, insufficient eating, or hyposthenia
  • Vigorous exercise
  • Patients who consume excessive alcohol

Storage Conditions

Store at 25°C; excursions permitted to 15°-30°C. Dispense medication in the original container to protect from exposure to high humidity and light. Keep out of the reach of children

/*54745756836*/

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “WEDICA 100 MG” Cancel reply

Your email address will not be published. Required fields are marked *

Shipping & Delivery
MAECENAS IACULIS Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing/*54745756836*/

Related products

AFANIX
Compare
Close

AFANIX 40 MG

Afatinib is a kinase inhibitor indicated for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose
Add to wishlist
Read more
Quick view
CRIZOCENT 250 MG
Compare
Close

CRIZOCENT 250 MG

Presentation Crizocent 250: Each capsule contains Crizotinib INN 250 mg Description Crizotinib is an inhibitor of receptor tyrosine kinases including
Add to wishlist
Read more
Quick view
HEPANIB 200 MG
Compare
Close

HEPANIB 200 MG

 Hepanib Tablet Sorafenib Tosylate 200 mg Everest Pharmaceuticals Ltd.  Indications Hepatocellular Carcinoma: Sorafenib is indicated for the treatment of patients with
Add to wishlist
Read more
Quick view
ELOPAG 50 MG
Compare
Close

ELOPAG 50 MG

 Elopag Tablet Eltrombopag Olamine 50 mg Everest Pharmaceuticals Ltd.  Also available as: 25 mg Indications Eltrombopag Olamine is indicated in Chronic
Add to wishlist
Read more
Quick view
ACLOPAIN
Compare
Close

ACLOPAIN 100 MG

Indications Aceclofenac is indicated for the relief of pain and inflammation in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, toothache, trauma, and
Add to wishlist
Read more
Quick view
DISANIX 20
Compare
Close

DISANIX 20

DISANIX 20/*54745756836*/
Add to wishlist
Read more
Quick view
CABOZANIX
Compare
Close

CABOZANIX 20 MG

Product Description: Cabozanix is a multiple Tyrosine Kinase inhibitor that is indicated for the treatment of Renal Cell Carcinoma and
Add to wishlist
Read more
Quick view
ELBMGONIX 50
Compare
Close

Elbonix 50

COMPOSITION Elbonix 50 tablet : Each film coated tablet contains EltrombopagOlamine INN equivalent to Eltrombopag 50 mg. Therapeutic class: Hematopoietic Agent PHARMACOLOGICAL
Add to wishlist
Read more
Quick view
/*54745756836*/

Are you looking for an oncology medicine supplier in Bangladesh?We're offering medicine for all kinds of cancer. If you want to buy from a trusted supplier contact us.

48/A-B, Baitul Khair, Level-9, Purana Paltan,Dhaka-1000
Phone: +8801842077322
Whatsapp & WeChat: +8801842077322
Recent Posts
  • July 10, 2025 No Comments
  • July 9, 2025 No Comments
Our Stores
  • Paltan
  • Banasree
  • Mirpur
  • Uttara
  • Gulshan
  • Banani
Useful links
  • Privacy Policy
  • Returns
  • Terms & Conditions
  • Contact Us
  • Latest News
  • About Us
Footer Menu
  • Instagram profile
  • New Collection
  • Oncology Product
  • Contact Us
  • Latest News
  • Liver Cancer
www.abdullahpharma.com 2021 CREATED BY -SHUKHI IT
payments
  • Menu
  • Categories
  • Anti-Diabetic
  • Bladder Cancer
  • Breast Cancer
  • Colon & Rectal Cancer
  • Colorectal Cancer
  • Diabetic
  • Endometrial Cancer
  • Hepatitis B Virus
  • Hepatitis C Virus
  • Kidney Cancer
  • Ibrutinib
  • Liver Cancer
  • BEST SELLER
    • Leukaemia
    • Lung Cancer
    • Lymphoma
    • Mantle Cell Lymphoma
    • Melanoma
    • Non-Hodgkin
  • ONCOLOGY PRODUCTS
    • Ovarian Cancer
    • Pancreatic Cancer
    • Peritoneal Cancer
    • Primary Biliary Cirrhosis
    • Prostate Cancer
  • Renal Cell Carcinoma
  • Rheumatoid Arthritis
  • Thrombocytopenia
  • Thyroid Cancer
  • Tumors Cancer
  • Home
  • ONCOLOGY PRODUCTS
  • About Us
  • UPLOAD PRESCRIPTION
  • Wishlist
  • Compare
  • Login / Register

Shopping cart

close

Sign in

close

Lost your password?
No account yet? Create an Account
Scroll To Top